Ellen Chiniara

General Counsel, ALERE INC.

Companies

Compass Therapeutics, Inc.Board member Apr 28, 2022 to now¹
Kymera TherapeuticsGeneral counsel Jan 4, 2023 to Mar 3, 2025²
Alexion PharmaceuticalsGeneral counsel Feb 22, 2018 to Jul 23, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kymera Therapeutics KYMR80,085 shares⁴$8.7M at $108.14Mar 3, 2025
Compass Therapeutics, Inc. CMPX0 shares⁵Apr 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 3, 2025Sold 408 shares at $31.00 of Kymera Therapeutics⁴
Mar 3, 2025Sold 1,833 shares at $30.33 of Kymera Therapeutics⁴
Mar 3, 2025Granted 27,500 shares of Kymera Therapeutics⁴
Jan 6, 2025Sold 3,129 shares at $41.75 of Kymera Therapeutics⁶
Mar 1, 2024Granted 21,755 shares of Kymera Therapeutics⁷
Jan 4, 2024Sold 3,295 shares at $22.58 of Kymera Therapeutics⁸
Jan 3, 2023Granted 37,500 shares of Kymera Therapeutics⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCompass Therapeutics, Inc., Board member
2
SEC EDGARKymera Therapeutics, General counsel
3
SEC EDGARAlexion Pharmaceuticals, General counsel
4
SEC EDGARKymera Therapeutics shares after the filing of Mar 3, 2025
5
SEC EDGARCompass Therapeutics, Inc. shares after the filing of Apr 28, 2022
6
SEC EDGARForm 4 filed Jan 6, 2025
7
SEC EDGARForm 4 filed Mar 4, 2024
8
SEC EDGARForm 4 filed Jan 5, 2024
9
SEC EDGARForm 4 filed Jan 4, 2023